Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233077 · ClinicalTrials.gov registry record · NA
Patient Centered Randomized Controlled Trial
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 374
- Enrollment target
NCT00233077 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 374 participants.
The verdict
NCT00233077, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 374 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patient-assistance programs as compared with usual care will help women with early stage breast cancer receive appropriate treatments.
Interventions
- BEHAVIORAL Information only
- BEHAVIORAL Patient Assistance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2006-10 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00233077
The ClinicalTrials.gov registry entry for NCT00233077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Information only is the first listed.
NCT00233077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00233077 about?
NCT00233077 is a clinical study titled "Patient Centered Randomized Controlled Trial". The purpose of this study is to determine whether patient-assistance programs as compared with usual care will help women with early stage breast cancer receive appropriate treatments.
What is the current status of trial NCT00233077?
This trial is currently completed. It is a NA study. The enrollment target is 374 participants. The study started on 2006-10. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00233077?
The interventions under investigation include: Information only (BEHAVIORAL), Patient Assistance (BEHAVIORAL).
Who is sponsoring clinical trial NCT00233077?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.